Scarica l'app Stockscreener
1.80
5.26%
-0.10
Pre-mercato:
1.79
-0.01
-0.56%
Precedente Chiudi:
$1.90
Aprire:
$1.87
Volume 24 ore:
48,639
Relative Volume:
0.02
Capitalizzazione di mercato:
$26.82M
Reddito:
$130.00K
Utile/perdita netta:
$-19.22M
Rapporto P/E:
-0.9501
EPS:
-1.8946
Flusso di cassa netto:
$-18.01M
1 W Prestazione:
-2.70%
1M Prestazione:
-15.09%
6M Prestazione:
-58.43%
1 anno Prestazione:
-68.25%
Intervallo 1D:
$1.79
$1.92
Intervallo di 1 settimana:
$1.7406
$1.9299
Portata 52W:
$1.22
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Nome
Serina Therapeutics Inc
Settore
Industria
Telefono
(256) 327-9630
Indirizzo
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
1.80 | 26.82M | 130.00K | -19.22M | -18.01M | -1.8946 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
Serina Therapeutics Inc Borsa (SER) Ultime notizie
Sio Capital (SER) reports 1,000,000 shares, 6.71% stake in Serina Therapeutics - Stock Titan
Serina Therapeutics (SER) Stock: Is It a Strong Investment Pick | Q4 2025: Earnings Beat EstimatesTrending Entry Points - Newser
SER Stock Price, Quote & Chart | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
Chart Pattern Insight | Serina Therapeutics notches 33% EPS beat, tops loss estimatesPost Earnings - Newser
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Serina Therapeutics (NYSE: SER) seeks share increase and equity plan changes in 2026 proxy - Stock Titan
Serina Therapeutics Updates Executive Leadership and Governance Structure - The Globe and Mail
Serina Therapeutics Appoints New CTO, Increases CEO Salary, and Amends Bylaws in April 2026 - Minichart
Serina Therapeutics promotes Srini Tenjarla to CTO and updates company bylaws By Investing.com - Investing.com South Africa
Serina Therapeutics promotes Srini Tenjarla to CTO and updates company bylaws - Investing.com Australia
Executive pay changes and new CTO at Serina Therapeutics (NYSE: SER) - Stock Titan
Serina Therapeutics (SER) director granted 59,667 dividend shares - Stock Titan
Director at Serina Therapeutics (SER) receives 7,553 share grant - Stock Titan
Serina names Srini Tenjarla CTO; raises CEO Steve Ledger's salary - TradingView
Serina Therapeutics, Inc. (SER) - Minichart
Share increase to 125M, 2M-plan reserve sought by Serina (NYSE: SER) - Stock Titan
Market Review: What is the dividend yield of Serina Therapeutics IncWeekly Trend Recap & Verified Momentum Stock Alerts - baoquankhu1.vn
Take Profit: What is the dividend yield of Serina Therapeutics IncMarket Growth Report & Free High Return Stock Watch Alerts - baoquankhu1.vn
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit - Sahm
Serina Therapeutics, Inc Announces Novel Lipid Nanoparticles Built On POZ Platform - marketscreener.com
Recap Report: Will PHUN be affected by tariffs2026 PreEarnings & Risk Controlled Swing Alerts - baoquankhu1.vn
Serina says its nanoparticle polymer avoided antibodies in rat study - Stock Titan
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan - Sahm
Serina Therapeutics wins NYSE approval; 2027 listing compliance deadline set - MSN
Serina Therapeutics announces NYSE American acceptance of continued listing compliance plan - marketscreener.com
Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance Plan - TradingView
SER Technical Analysis & Stock Price Forecast - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Serina Therapeutics (SER) files 10-K amendment to correct auditor consent - stocktitan.net
New funding to support Serina’s SER-252 trial in advanced Parkinson’s - Parkinson's News Today
SER Stock Price and Chart — AMEX:SER - TradingView
Serina Therapeutics POZ Drug Delivery Platform: Technology Overview, Pipeline, and Intellectual Property Portfolio - Minichart
Serina Therapeutics' 2025 net loss widens as R&D expenses jump - TradingView
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights - marketscreener.com
Serina Therapeutics (NYSE: SER) posts 2025 loss while funding SER-252 trials - Stock Titan
[10-K] Serina Therapeutics, Inc. Fi... - Stock Titan
Serina Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Top Executive Makes Notable Move With Serina Therapeutics Stock - TipRanks
Serina Therapeutics CSO Moreadith sells $18,567 in stock - Investing.com
Serina Therapeutics CSO Moreadith sells $18,567 in stock By Investing.com - Investing.com Canada
Serina Therapeutics (SER) CSO exercises options then sells 6,500 shares - Stock Titan
Serina Therapeutics Raises Up to $30 Million to Advance SER-252 Parkinson’s Drug Trial and Secures Additional Funding Opportunities - Minichart
Serina Therapeutics to Present at 38th Annual Roth Conference - National Today
Serina Therapeutics to Present at the 38th Annual Roth Conference - Bitget
Serina Therapeutics Inc appoints Greg Bailey as co-chairman of boardSEC filing - MarketScreener
Serina Therapeutics IncAppoints Greg Bailey As Co-Chairman Of BoardSEC Filing - TradingView — Track All Markets
Serina Therapeutics (SER) lines up $30M private placement plus $33.3M warrant upside - Stock Titan
Serina Therapeutics Inc. Faces Stock Volatility Amid Economic Challenges - StocksToTrade
Serina Therapeutics Inc Azioni (SER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Capitalizzazione:
|
Volume (24 ore):